Search results
Results from the WOW.Com Content Network
The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. Founded in 1812, the journal is among the most prestigious peer-reviewed medical journals. [1] Its 2023 impact factor was 96.2, ranking it 2nd out of 168 journals in the category "Medicine, General & Internal". [2]
After introducing medically assisted treatment in 2013, Seppala saw Hazelden’s dropout rate for opiate addicts in the new revamped program drop dramatically. Current data, which covers between January 1, 2013 and July 1, 2014, shows a dropout rate of 7.5 percent compared with the rate of 22 percent for the opioid addicts not in the program.
NEJM Journal Watch is a series of topic-specific newsletters written for physicians and other health professionals. It is published by the Massachusetts Medical Society and is a sibling publication to the New England Journal of Medicine. NEJM Journal Watch distributes its products via print, e-mail, and its website.
In 2017, the letter attracted renewed interest because the New England Journal of Medicine published a bibliographic analysis of the letter showing that it had been cited 608 times since it was published. In comparison, the other letters to the editor in the same issue of the Journal as Porter and Jick's letter had been cited a median of 11 ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Angell joined the editorial staff of The New England Journal of Medicine (NEJM) in 1979. She became Executive Editor in 1988, and served as interim Editor-in-Chief from 1999 until June 2000. [ 3 ] The NEJM is the oldest continuously published medical journal, [ 4 ] and one of the most prestigious; Angell is the first woman to have served as ...
Recent changes; Upload file ... race is an important social issue affecting patient and ... Minority Communities" at New England Journal of Medicine ...
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each month, an industry group told the U.S. drugs regulator in a letter ...